Bank Of New York Mellon Corp Myriad Genetics Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $11.8 Million - $17 Million	811,188 New	811,188 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $309,733 - $474,210	17,009 Added 2.06%	841,423 $16.1 Million
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $1.67 Million - $2.63 Million	-101,548 Reduced 10.97%	824,414 $15 Million
Q1 2022 May 11, 2022	SELL	$22.67 - $28.01 $186,279 - $230,158	-8,217 Reduced 0.88%	925,962 $23.3 Million
Q4 2021 Feb 11, 2022	BUY	$24.13 - $32.63 $167,679 - $226,745	6,949 Added 0.75%	934,179 $25.8 Million
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $948,310 - $1.16 Million	31,642 Added 3.53%	927,230 $29.9 Million
Q2 2021 Aug 11, 2021	SELL	$25.39 - $32.61 $88,560 - $113,743	-3,488 Reduced 0.39%	895,588 $27.4 Million
Q1 2021 May 13, 2021	BUY	$19.92 - $31.6 $75,297 - $119,448	3,780 Added 0.42%	899,076 $27.4 Million
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $579,545 - $942,238	-47,660 Reduced 5.05%	895,296 $17.7 Million
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $13,961 - $18,304	-1,241 Reduced 0.13%	942,956 $12.3 Million
Q2 2020 Aug 12, 2020	BUY	$10.69 - $16.49 $559,332 - $862,806	52,323 Added 5.87%	944,197 $10.7 Million
Q1 2020 May 06, 2020	SELL	$9.78 - $29.53 $377,155 - $1.14 Million	-38,564 Reduced 4.14%	891,874 $12.8 Million
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $1.49 Million - $2.51 Million	-71,377 Reduced 7.12%	930,438 $25.3 Million
Q3 2019 Nov 07, 2019	SELL	$22.08 - $47.08 $898,258 - $1.92 Million	-40,682 Reduced 3.9%	1,001,815 $28.7 Million
Q2 2019 Aug 12, 2019	BUY	$22.67 - $35.0 $2.29 Million - $3.54 Million	101,064 Added 10.74%	1,042,497 $29 Million
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $1.2 Million - $1.54 Million	-44,471 Reduced 4.51%	941,433 $31.3 Million
Q4 2018 Feb 11, 2019	BUY	$27.23 - $45.56 $2.07 Million - $3.46 Million	75,872 Added 8.34%	985,904 $28.7 Million
Q3 2018 Nov 09, 2018	BUY	$37.57 - $50.34 $2.1 Million - $2.82 Million	55,974 Added 6.55%	910,032 $0
Q2 2018 Aug 06, 2018	SELL	$27.75 - $40.17 $1.01 Million - $1.46 Million	-36,265 Reduced 4.07%	854,058 $31.9 Million
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $834,484 - $1.19 Million	28,945 Added 3.36%	890,323 $26.3 Million
Q4 2017 Feb 09, 2018	BUY	$28.45 - $37.14 $24.5 Million - $32 Million	861,378	861,378 $29.6 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$208 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$142 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$92.3 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$71.1 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$64.6 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account